728 results on '"Van Meerbeeck, Jan P."'
Search Results
2. Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
3. DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis
4. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)
5. Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating Mood
6. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
7. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review
8. Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based study
9. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
10. Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions
11. Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited-Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial
12. Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter Study
13. Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results
14. Determining the clinical utility of a breath test to screen an asbestos-exposed population for pleural mesothelioma.
15. Exhaled breath analysis optimizes nodule management in a lung cancer screening program.
16. Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology Patients
17. Quality of care and variability in lung cancer management across Belgian hospitals : a population-based study using routinely available data
18. Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy
19. Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma
20. Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies
21. Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial
22. Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study
23. The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
24. Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy
25. Imaging of urgencies and emergencies in the lung cancer patient
26. Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology
27. Surgical series in mesothelioma: navigating between biases
28. Editorial: Imaging assessment of response to immunotherapy
29. Commonly used Cytotoxic Agents in Thoracic Oncology
30. What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
31. Mesothelioma treatment: Are we on target? A review
32. A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in Belgium
33. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4 /6 inhibition
34. The need for a comprehensive and integrated approach to lung cancer policy in Europe
35. Tri-Modality Therapy in Locally Advanced Non-Small-Cell Lung Cancer
36. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
37. New Implications of Patients’ Sex in Today’s Lung Cancer Management
38. Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
39. Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials
40. External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
41. Lung Cancer Screening: New Perspective and Challenges in Europe
42. Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
43. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition
44. The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?
45. Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption
46. A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in Belgium.
47. Implicit attitudes towards smoking predict long-term relapse in abstinent smokers
48. Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future
49. The Effect of Clinical Covariates on the Diagnostic and Prognostic Value of Soluble Mesothelin and Megakaryocyte Potentiating Factor
50. Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.